Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Payables (2019 - 2026)

IM Cannabis has reported Payables over the past 8 years, most recently at $6.0 million for Q1 2026.

  • For Q1 2026, Payables changed N/A year-over-year to $6.0 million; the TTM value through Mar 2026 reached $6.0 million, changed N/A, while the annual FY2025 figure was $18.9 million, 1.51% down from the prior year.
  • Payables was $6.0 million for Q1 2026 at IM Cannabis, down from $18.9 million in the prior quarter.
  • Across five years, Payables topped out at $18.9 million in Q4 2025 and bottomed at $1.2 million in Q2 2024.
  • The 5-year median for Payables is $16.9 million (2023), against an average of $13.1 million.
  • Year-over-year, Payables soared 70.81% in 2022 and then decreased 13.35% in 2023.
  • Over 5 years, Payables stood at $18.1 million in 2022, then dropped by 13.35% to $15.7 million in 2023, then rose by 20.11% to $18.8 million in 2024, then increased by 0.49% to $18.9 million in 2025, then tumbled by 68.38% to $6.0 million in 2026.
  • The last three reported values for Payables were $6.0 million (Q1 2026), $18.9 million (Q4 2025), and $18.8 million (Q4 2024) per Business Quant data.